Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: Treatment outcomes with imatinib mesylate [1]

Ruben A. Mesa, David P. Steensma, James Hoyer, Rhett P. Ketterling

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)366-367
Number of pages2
JournalBritish journal of haematology
Volume123
Issue number2
DOIs
StatePublished - Oct 2003

Keywords

  • Chronic myeloid leukaemia
  • Imatinib mesylate
  • Myelodysplastic syndrome
  • t(9;22) subclone

ASJC Scopus subject areas

  • Hematology

Cite this